Results of the phase 1 trial of RG7112, a small-molecule MDM2 antagonist in leukemia

Michael Andreeff, Kevin R. Kelly, Karen Yee, Sarit Assouline, Roger Strair, Leslie Popplewell, David Bowen, Giovanni Martinelli, Mark W. Drummond, Paresh Vyas, Mark Kirschbaum, Swaminathan Padmanabhan Iyer, Vivian Ruvolo, Graciela M Nogueras Gonzalez, Xuelin Huang, Gong Chen, Bradford Graves, Steven Blotner, Peter Bridge, Lori JukofskySteve Middleton, Monica Reckner, Ruediger Rueger, Jianguo Zhi, Gwen Nichols, Kensuke Kojima

Research output: Contribution to journalArticlepeer-review

267 Scopus citations

Fingerprint

Dive into the research topics of 'Results of the phase 1 trial of RG7112, a small-molecule MDM2 antagonist in leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases